Bandingkan Harga & Kinerja Brigit Biofarmaka Teknologi Tbk. (OBAT) vs Solusi Tunas Pratama Tbk. (SUPR)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Brigit Biofarmaka Teknologi Tbk. dan Solusi Tunas Pratama Tbk.: Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp240 (kapitalisasi pasar 166,01 M, volume 24 jam 324 rb), sedangkan Solusi Tunas Pratama Tbk. diperdagangkan di Rp43.850 (kapitalisasi pasar 49,88 T). Perbedaan utamanya: Solusi Tunas Pratama Tbk. jauh lebih besar — sekitar 300,5× kapitalisasi pasar Brigit Biofarmaka Teknologi Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| OBAT | SUPR | |
|---|---|---|
Kapitalisasi Pasar | 166,01 M | 49,88 T |
Volume | 324 rb | — |
Lot | 3,24 rb | — |
Perputaran | 77,68 jt | — |
Harga Rata-rata | 239,75 | — |
Nilai Transaksi | 77,68 jt | — |
Harga Ekuilibrium Indikatif | 240 | — |
Volume Ekuilibrium Indikatif | 1 | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Selengkapnya di halaman OBAT →Tentang Solusi Tunas Pratama Tbk.
PT Solusi Tunas Pratama Tbk (the company) was established based on the Deed No.5 dated Jul 25, 2006 made in presence of Ridjqi Nurdiani, S.H, a Notary in Bekasi. The Company's articles of association has been amended from time to time, the latest amendment regarding the decrease in nominal value of the Company's shares, the change in the Company's name and the change in the Company's status from private company to public company.
Selengkapnya di halaman SUPR →
